Annovis Bio Issued European Patent for Method of Treating Alzheimer’s Disease with ANVS401
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced the European Patent Office …
Read More